Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Men only

Pelvic floor therapies for lifelong premature ejaculation

Official title: Electromagnetic Pelvic Floor Stimulation Versus Biofeedback-Assisted and Conventional Pelvic Floor Muscle Training in Men With Lifelong Premature Ejaculation: A Randomized Controlled Trial

Run by Tanta University · NCT07627438 · Data updated 2026-11-12

This study tests three pelvic floor treatments (electromagnetic stimulation, biofeedback-assisted training, and standard training) to see which helps men with lifelong premature ejaculation last longer during sex.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexMen only
Enrollment150 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Tanta)
StatusRecruiting
StartedApril 26, 2026
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedJune 4, 2026
Trial IDNCT07627438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men 18–50 with lifelong premature ejaculation (IELT < 1 minute) who consent to follow-up and do not have erectile dysfunction or relevant neurological or surgical exclusions.

Probably not a fit

Men outside the age range, without lifelong PE, or with conditions listed in the exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will compare electromagnetic pelvic floor stimulation, biofeedback-assisted pelvic floor muscle training, and conventional pelvic floor muscle training in 150 men aged 18 to 50 with lifelong premature ejaculation (intravaginal ejaculatory latency time under 1 minute). The primary outcome is change in stopwatch-measured ejaculatory latency time after 6 weeks of treatment. Secondary outcomes include changes in diagnostic and erectile function scores, patient- and partner-satisfaction, treatment adherence, and adverse events. Participants are recruited from the Urology Department at Tanta University after informed consent and are randomized 1:1:1 to one of the three interventions. The trial aims to clarify whether these non-pharmacological options can improve ejaculatory control and overall sexual well-being.

Why it matters

Potential benefit: If successful, participants could experience longer ejaculatory latency and improved sexual satisfaction.

How similar studies have gone: Prior research suggests pelvic floor approaches can help, but results vary and this study adds a direct comparison among three modalities.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men aged 18 to 50 years.
* Diagnosis of lifelong premature ejaculation.
* Intravaginal ejaculatory latency time less than 1 minute.
* Ability and willingness to comply with the treatment protocol and follow-up visits.
* Written informed consent.

Exclusion Criteria:

* Erectile dysfunction.
* Neurological disease.
* Previous pelvic surgery.

Where it's running

  • Department of Urology- Tanra University Hospitals
    Tanta, Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.